BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17673129)

  • 1. Radioiodine in the treatment of thyroid cancer.
    Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):807-22, vii-viii. PubMed ID: 17673129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
    Ylli D; Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):181-197. PubMed ID: 30717901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
    Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
    Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
    Dietlein M; Dressler J; Eschner W; Grünwald F; Lassmann M; Leisner B; Luster M; Moser E; Reiners C; Schicha H; Schober O; ;
    Nuklearmedizin; 2007; 46(5):213-9. PubMed ID: 17938757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
    Lassmann M; Reiners C; Luster M
    Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies, Consensus, and Collaboration in the Use of
    Tuttle RM; Ahuja S; Avram AM; Bernet VJ; Bourguet P; Daniels GH; Dillehay G; Draganescu C; Flux G; Führer D; Giovanella L; Greenspan B; Luster M; Muylle K; Smit JWA; Van Nostrand D; Verburg FA; Hegedüs L
    Thyroid; 2019 Apr; 29(4):461-470. PubMed ID: 30900516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiated thyroid cancer in children: diagnosis and management.
    Dinauer CA; Breuer C; Rivkees SA
    Curr Opin Oncol; 2008 Jan; 20(1):59-65. PubMed ID: 18043257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of dosimetry in the treatment of differentiated thyroid cancer.
    Lassmann M; Hänscheid H; Verburg FA; Luster M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):107-15. PubMed ID: 21386785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioiodine therapy of differentiated thyroid cancer. Recommendations of the Therapy Study Group of the German Society of Nuclear Medicine].
    Georgi P; Emrich D; Heidenreich P; Moser E; Reiners C; Schicha H
    Nuklearmedizin; 1992 Aug; 31(4):151-3. PubMed ID: 1518724
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative use of radioiodine (131-I): review of recommendations and guidelines.
    Prpić M; Jukić T; Murgić J; Borić M; Stanicić J; Kusić Z
    Coll Antropol; 2011 Jun; 35(2):587-94. PubMed ID: 21755735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redifferentiating agents in non-radioiodine avid cancer.
    Seregni E; Vellani C; Castellani MR; Maccauro M; Pallotti F; Scaramellini G; Guzzo M; Greco A
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):513-9. PubMed ID: 19910904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial radioiodine administration: when to use it and how to select the dose.
    Esposito G
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine ablation for differentiated thyroid cancer-none, one dose or two?
    Rees GJ
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):131-5. PubMed ID: 19969444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of thyroid carcinoma using radioiodine].
    Santora J; Nĕmec J; Kubinyi J
    Cas Lek Cesk; 2001 Apr; 140(7):217-9. PubMed ID: 11374227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
    Clarke SE
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioiodine treatment for malignant thyroid disease.
    Berg G
    Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
    Al-Shakhrah IA
    Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.